Science Creates

Member

Active

Status

2019

Founded

Seed

Development stage

Charity supporter
Old Market
Incubator residents

GenomeKey is transforming how healthcare clinicians diagnose and treat infections like sepsis to improve patient outcomes. Using cutting-edge machine learning and DNA sequencing, the company is developing a next-generation diagnostic device to identify bacterial genomes and determine their antimicrobial susceptibility directly from patient blood in just a few hours, rather than days. This enables clinicians to prescribe the right antibiotics for patients with much more efficiency and accuracy, reducing costs, minimising unnecessary antibiotic use and ultimately saving millions of lives from the world’s leading cause of death.

Founding team

Key contacts

Michael Roberts

CEO

Michael is a business and technology leader. He earned his doctorate in Computational Photonics from Heriot-Watt University focussing on the application of machine learning to complex human behavioural patterns and computer vision problems. Michael has experience bringing novel capability and applications from conception to product in genomics, defence, oil and gas, and law enforcement industries.

Chris Heys

CTO

Ben Hadlow

Chief Information Security Officer

Ben leads information technology, infrastructure and information security for GenomeKey. He brings over 9 years of industry experience in security architecting, secure software design and systems administration. Ben also brings business, operational and financial expertise to the team.

Dan Rogerson

CSO

Daniel is an experienced molecular biologist who has a background in developing in vitro diagnostics for sepsis detection, protein engineering, DNA sequencing and various molecular techniques relevant to the sample preparation challenges in this project. Dr. Rogerson completed his PhD and postdoctoral studies at the MRC Laboratory for Molecular Biology (LMB), University of Cambridge.

Back to directory